Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Iorio

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Rheumatology (Oxford, England)|March 12, 2025
Advances in the treatment of polymyalgia rheumaticaLuca Iorio, Milena Bond, Roberto Padoan, et al.
Expert Opinion on Investigational Drugs|June 16, 2024
Investigational agents for polymyalgia rheumatica treatment: assessing the critical needs for future developmentLuca Iorio, Roberto Padoan, Milena Bond, et al.
Expert Opinion on Biological Therapy|March 1, 2022
Biologic therapy in relapsing polychondritis: navigating between optionsRoberto Padoan, Debora Campaniello, Luca Iorio, et al.
Autoimmunity Reviews|December 15, 2023
Combination of monoclonal antibodies targeting type 2 inflammation for severe asthma and eosinophilic granulomatosis with polyangiitisFederica Davanzo, Maria Rita Marchi, Luca Iorio, et al.
ACR Open Rheumatology|January 12, 2026
Outcomes of an Intravenous to Subcutaneous Infliximab (CT-P13) Strategy in Takayasu Arteritis: A Proof-of-Concept Prospective StudyLuca Iorio, Federica Davanzo, Eleonora Fiorin, et al.
Autoimmunity Reviews|August 25, 2023
Subclinical giant cell arteritis in polymyalgia rheumatica: Concurrent conditions or a common spectrum of inflammatory diseases?Carlo Salvarani, Roberto Padoan, Luca Iorio, et al.
Rheumatology (Oxford, England)|August 5, 2024
Epstein-Barr virus-positive lymphoproliferative disorder mimicking eosinophilic granulomatosis with polyangiitisLuca Iorio, Marco Pizzi, Federica Davanzo, et al.
Scientific Reports|December 9, 2023
Reinforcement learning optimisation for graded metamaterial design using a physical-based constraint on the state representation and action spaceLuca Rosafalco, Jacopo Maria De Ponti, Luca Iorio, et al.
Autoimmunity Reviews|August 31, 2023
Might maintenance therapy be discontinued once clinical remission is achieved in ANCA-associated vasculitis?Dario Roccatello, Roberto Padoan, Savino Sciascia, et al.
Journal of Clinical Medicine|September 14, 2024
Cocaine- and Levamisole-Induced Vasculitis: Defining the Spectrum of Autoimmune ManifestationsLuca Iorio, Federica Davanzo, Diego Cazzador, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Rheumatology (Oxford, England)|March 12, 2025
Advances in the treatment of polymyalgia rheumaticaLuca Iorio, Milena Bond, Roberto Padoan, et al.
Expert Opinion on Investigational Drugs|June 16, 2024
Investigational agents for polymyalgia rheumatica treatment: assessing the critical needs for future developmentLuca Iorio, Roberto Padoan, Milena Bond, et al.
Expert Opinion on Biological Therapy|March 1, 2022
Biologic therapy in relapsing polychondritis: navigating between optionsRoberto Padoan, Debora Campaniello, Luca Iorio, et al.
Autoimmunity Reviews|December 15, 2023
Combination of monoclonal antibodies targeting type 2 inflammation for severe asthma and eosinophilic granulomatosis with polyangiitisFederica Davanzo, Maria Rita Marchi, Luca Iorio, et al.
ACR Open Rheumatology|January 12, 2026
Outcomes of an Intravenous to Subcutaneous Infliximab (CT-P13) Strategy in Takayasu Arteritis: A Proof-of-Concept Prospective StudyLuca Iorio, Federica Davanzo, Eleonora Fiorin, et al.
Autoimmunity Reviews|August 25, 2023
Subclinical giant cell arteritis in polymyalgia rheumatica: Concurrent conditions or a common spectrum of inflammatory diseases?Carlo Salvarani, Roberto Padoan, Luca Iorio, et al.
Rheumatology (Oxford, England)|August 5, 2024
Epstein-Barr virus-positive lymphoproliferative disorder mimicking eosinophilic granulomatosis with polyangiitisLuca Iorio, Marco Pizzi, Federica Davanzo, et al.
Scientific Reports|December 9, 2023
Reinforcement learning optimisation for graded metamaterial design using a physical-based constraint on the state representation and action spaceLuca Rosafalco, Jacopo Maria De Ponti, Luca Iorio, et al.
Autoimmunity Reviews|August 31, 2023
Might maintenance therapy be discontinued once clinical remission is achieved in ANCA-associated vasculitis?Dario Roccatello, Roberto Padoan, Savino Sciascia, et al.
Journal of Clinical Medicine|September 14, 2024
Cocaine- and Levamisole-Induced Vasculitis: Defining the Spectrum of Autoimmune ManifestationsLuca Iorio, Federica Davanzo, Diego Cazzador, et al.
Pageof 4